169 related articles for article (PubMed ID: 22892815)
1. Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio.
Verdonk K; Visser W; Russcher H; Danser AH; Steegers EA; van den Meiracker AH
Hypertension; 2012 Oct; 60(4):884-90. PubMed ID: 22892815
[No Abstract] [Full Text] [Related]
2. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.
Lapaire O; Shennan A; Stepan H
Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):122-9. PubMed ID: 20457483
[TBL] [Abstract][Full Text] [Related]
3. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.
Vatten LJ; Eskild A; Nilsen TI; Jeansson S; Jenum PA; Staff AC
Am J Obstet Gynecol; 2007 Mar; 196(3):239.e1-6. PubMed ID: 17346536
[TBL] [Abstract][Full Text] [Related]
4. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 are significantly related to PAPP-A levels.
Gruson D; Yuemo CD; Classen JF; Lepoutre T; Piquard N; Debiève F
Clin Chem Lab Med; 2013 Apr; 51(4):e49-51. PubMed ID: 23072855
[No Abstract] [Full Text] [Related]
5. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
Andersen LB; Frederiksen-Møller B; Work Havelund K; Dechend R; Jørgensen JS; Jensen BL; Nielsen J; Lykkedegn S; Barington T; Christesen HT
J Am Soc Hypertens; 2015 Feb; 9(2):86-96. PubMed ID: 25600419
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
8. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
Woodham PC; Brittain JE; Baker AM; Long DL; Haeri S; Camargo CA; Boggess KA; Stuebe AM
Hypertension; 2011 Dec; 58(6):1120-5. PubMed ID: 21986503
[TBL] [Abstract][Full Text] [Related]
9. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
10. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
Unal ER; Robinson CJ; Johnson DD; Chang EY
Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
[TBL] [Abstract][Full Text] [Related]
12. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
Qazi U; Lam C; Karumanchi SA; Petri M
J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
[TBL] [Abstract][Full Text] [Related]
13. Circulating angiogenic factors and preeclampsia.
Tsatsaris V; Goffin F; Foidart JM
N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904
[No Abstract] [Full Text] [Related]
14. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
Hanita O; Alia NN; Zaleha AM; Nor Azlin MI
Malays J Pathol; 2014 Apr; 36(1):19-26. PubMed ID: 24763231
[TBL] [Abstract][Full Text] [Related]
15. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
[TBL] [Abstract][Full Text] [Related]
16. Performance of soluble fms-like tyrosine kinase-1-to-placental growth factor ratio of ≥85 for ruling in preeclampsia within 4 weeks.
Cerdeira AS; O'Sullivan J; Ohuma EO; James T; Papageorghiou AT; Knight M; Vatish M
Am J Obstet Gynecol; 2021 Mar; 224(3):322-323. PubMed ID: 33207235
[No Abstract] [Full Text] [Related]
17. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies.
Maynard SE; Moore Simas TA; Solitro MJ; Rajan A; Crawford S; Soderland P; Meyer BA
Am J Obstet Gynecol; 2008 Feb; 198(2):200.e1-7. PubMed ID: 18226624
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays.
Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
Am J Obstet Gynecol; 2011 Nov; 205(5):469.e1-8. PubMed ID: 21903191
[TBL] [Abstract][Full Text] [Related]
19. [The placental growth factor and fms-similar tyrosine kinase-1 as markers of pre-eclampsy in dynamics of pregnancy].
Ivanets TIu; Alekseeva ML; Loginova NS; Kolod'ko VG; Nasonova DM; Kha'sianova ZSh
Klin Lab Diagn; 2013 Aug; (8):14-7. PubMed ID: 24340742
[TBL] [Abstract][Full Text] [Related]
20. [The role of angiogenic factors in preeclampsia].
Alasztics B; Gullai N; Molvarec A; Rigó J
Orv Hetil; 2014 Nov; 155(47):1860-6. PubMed ID: 25403279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]